CClinicalTrials.gg
CompletedNCT03309072Updated Feb 3, 2022Results posted

Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task

An interventional study of tDCS and sham tDCS in Healthy Adults, sponsored by The University of Texas at Dallas. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-03.

Sponsored by The University of Texas at Dallas · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The purpose of this study is to investigate whether we can accelerate learning and improve associative memory performance in healthy subjects by applying transcranial Direct Current Stimulation (tDCS) during a Face Name memory task.

Read the detailed description

Associative memory refers to remembering the association between two items, such as a face and a name or a word in English and the same word in another language. It is not only important for learning, but it is also one of the first aspects of memory performance that is impacted by aging and by Alzheimer׳s disease. For decades, neuroscientists have investigated associative learning and memory and ways to accelerate and enhance associative learning and memory.

Transcranial Direct Current stimulation (tDCS) is a non-invasive and painless electrical stimulation technique that has demonstrated to accelerate learning and improve memory in some studies. To investigate whether we can accelerate learning and improve associative memory using tDCS, we will compare the performance in a Face Name Associate memory task from 2 groups. The first group will get active tDCS during the study phase of the Face Name Memory task, whereas the second group will get sham tDCS during the study phase of the task.

02

Conditions studied

  • Healthy Adults

Keywords

  • transcranial Direct Current Stimulation (tDCS)
  • accelerated learning
  • memory
03

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age: 18-35 years
  • Native English Speaker

Exclusion criteria

Exclusion Criteria:

  • History of severe head injuries, epileptic insults, or heart disease.
  • Severe psychiatric disorders and severe untreated medical problems.
  • Contraindications for tDCS (pregnant women, implanted devices)
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    active tDCS

    active tDCS with Face Name associate Memory task

    Device: tDCS

  • Sham comparator
    sham tDCS

    sham tDCS with Face Name associate Memory task

    Device: sham tDCS

Interventions

  • DevicetDCS

    active tDCS

  • Devicesham tDCS

    sham tDCS

05

What researchers measure

Primary outcomes

  1. Associative Memory Assessed by a Face Name Associate Memory Experiment

    All participants performed a face memory task .The face stimuli consisted of 120 grayscale pictures of human faces. Only faces with a neutral expression facing forward were selected. Half of the faces were male, and the other half were female. The face-name association memory task was divided into (1) an encoding phase, (2) a consolidation phase, and (3) a retrieval phase. During the encoding phase, participants studied 60 successively presented face-name pairs and were instructed to assess their gender to keep them focused to the task. The encoding phase was followed by a consolidation phase where participants were instructed to "sit still, relax, and think about nothing in particular" for 10 minutes, During the retrieval phase, participants were presented with 60 old and 60 new faces and were instructed to assess whether they have seen this face during the encoding phase. The outcome was the percent of Correct Name to Face Matches

    Time frame: Associate Memory is assessed after a 10 minutes break following the study phase

06

Results

Posted Sep 11, 2020

Participant flow

1. Age between 18 and 35 2. Currently not using any medication 3. Native English speaker 4. Capable of understanding and signing an informed consent

Participant flow — Overall Study
MilestoneActive tDCSSham tDCS
Started1515
Completed1515
Not completed00

Outcome measures

PrimaryAssociative Memory Assessed by a Face Name Associate Memory Experiment

All participants performed a face memory task .The face stimuli consisted of 120 grayscale pictures of human faces. Only faces with a neutral expression facing forward were selected. Half of the faces were male, and the other half were female. The face-name association memory task was divided into (1) an encoding phase, (2) a consolidation phase, and (3) a retrieval phase. During the encoding phase, participants studied 60 successively presented face-name pairs and were instructed to assess their gender to keep them focused to the task. The encoding phase was followed by a consolidation phase where participants were instructed to "sit still, relax, and think about nothing in particular" for 10 minutes, During the retrieval phase, participants were presented with 60 old and 60 new faces and were instructed to assess whether they have seen this face during the encoding phase. The outcome was the percent of Correct Name to Face Matches

Time frame:
Associate Memory is assessed after a 10 minutes break following the study phase
Reported as:
Mean · Percent of Correct Name to Face Matches
Associative Memory Assessed by a Face Name Associate Memory Experiment
Percent of Correct Name to Face MatchesActive tDCSSham tDCS
Associative Memory Assessed by a Face Name Associate Memory Experiment44.22 ± 11.5435.44 ± 12.04
Statistical analysis
  • Active tDCS vs Sham tDCS · ANOVA · p = <.049 · Mean difference (net): 10.66Difference between active tDCS and sham tDCS

Adverse events

Collected over 1 week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Active tDCS0/15 (0%)0/15 (0%)0/15 (0%)
Sham tDCS0/15 (0%)0/15 (0%)0/15 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Active tDCSSham tDCSTotal
Mean19.67 ± 2.520.6 ± 3.920.13 ± 3.26
Sex: Female, Male
Sex: Female, Male(Participants)Active tDCSSham tDCSTotal
Female101222
Male538
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Active tDCSSham tDCSTotal
American Indian or Alaska Native000
Asian5813
Native Hawaiian or Other Pacific Islander000
Black or African American011
White6410
More than one race123
Unknown or Not Reported303
Region of Enrollment
Region of Enrollment(participants)Active tDCSSham tDCSTotal
United States151530
Beck Depression Inventory Scale
Beck Depression Inventory Scale(units on a scale)Active tDCSSham tDCSTotal
Mean5.20 ± 3.613.47 ± 3.624.33 ± 3.66
Beck Anxiety Inventory Scale
Beck Anxiety Inventory Scale(units on a scale)Active tDCSSham tDCSTotal
Mean4.53 ± 3.382.67 ± 2.853.60 ± 3.21
Mini Mental State Examination
Mini Mental State Examination(units on a scale)Active tDCSSham tDCSTotal
Mean28.9 ± 0.8828.5 ± 1.5128.7 ± 1.24
Profile of Mood States- Mood Disturbance
Profile of Mood States- Mood Disturbance(units on a scale)Active tDCSSham tDCSTotal
Mean10.27 ± 23.21.47 ± 11.334.4 ± 18.9
07

Study locations

1 site
  • The University of Texas of Dallas
    Richardson, Texas 75080, United States
08

References and documents

Study documents

  • Study protocol · Jan 1, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03309072
Lead sponsor
The University of Texas at Dallas
Responsible party
Sven Vanneste (Associate professor, The University of Texas at Dallas) — Principal investigator
First posted
Oct 13, 2017
Start date
Sep 27, 2017
Primary completion
Jan 25, 2022
Completion
Jan 25, 2022
Results posted
Sep 11, 2020
Last update
Feb 3, 2022

Study contacts

Sven Vanneste, PhD
principal investigator · The University of Texas at Dallas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion